Related Experiment Video
Updated: Mar 23, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
CYP1B1-mediated Pathobiology of Primary Congenital Glaucoma
Muneeb A Faiq1, Rima Dada2, Rizwana Qadri3
1Student, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Abstract:
CYP1B1 is a dioxin-inducible enzyme belonging to the cytochrome P450 superfamily. It has been observed to be important in a variety of developmental processes including in utero development of ocular structures. Owing to its role in the developmental biology of eye, its dysfunction can lead to ocular developmental defects. This has been found to be true and CYP1B1 mutations have been observed in a majority of primary congenital glaucoma (PCG) patients from all over the globe. Primary congenital glaucoma is an irreversibly blinding childhood disorder (onset at birth or early infancy) typified by anomalous development of trabecular meshwork (TM). How CYP1B1 causes PCG is not known; however, some basic investigations have been reported. Understanding the CYP1B1 mediated etiopathomechanism of PCG is very important to identify targets for therapy and preventive management. In this perspective, we will make an effort to reconstruct the pathomechanism of PCG in the light of already reported information about the disease and the CYP1B1 gene. How to cite this article: Faiq MA, Dada R, Qadri R, Dada T. CYP1 B1-mediated Pathobiology of Primary Congenital Glaucoma. J Curr Glaucoma Pract 2015;9(3):77-80.
Insights
Mutations in the CYP1B1 gene are linked to primary congenital glaucoma (PCG), a severe childhood eye disorder. Understanding CYP1B1
Area of Science:
- Ophthalmology
- Genetics
- Biochemistry
Background:
- Cytochrome P450 family 1 member B1 (CYP1B1) is a dioxin-inducible enzyme crucial for ocular development.
- Dysfunction of CYP1B1 is implicated in congenital ocular developmental defects.
- Primary congenital glaucoma (PCG) is a blinding childhood disorder characterized by abnormal trabecular meshwork development.
Purpose of the Study:
- To elucidate the role of CYP1B1 in the pathobiology of primary congenital glaucoma.
- To reconstruct the etiopathomechanism of PCG mediated by CYP1B1.
- To identify potential therapeutic targets for PCG.
Main Methods:
- Review and synthesis of existing literature on CYP1B1 gene and primary congenital glaucoma.
- Analysis of reported CYP1B1 mutations in PCG patients.
- Reconstruction of the pathomechanism based on current knowledge.
Main Results:
- CYP1B1 mutations are found in a significant majority of primary congenital glaucoma patients globally.
- CYP1B1 plays a critical role in the in utero development of ocular structures.
- The precise mechanism by which CYP1B1 dysfunction leads to PCG remains under investigation.
Conclusions:
- CYP1B1 is a key gene associated with primary congenital glaucoma.
- Further understanding of CYP1B1's role is essential for developing effective therapies and preventive strategies for PCG.
- Targeting CYP1B1 pathways may offer new avenues for PCG treatment.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Photoreceptors and Visual Pathways
Angle Closure Glaucoma: Treatment
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Genetic Lingo

